Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin vs DJ Stenting after Ureteroscopic Lithotripsy
NCT05823662Completed
- Sponsor
- Benha University
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of silodosin in ureteric stone, sponsored by Benha University. Primary endpoint: Stone-free rate at 3 weeks. Started Mar 2022; status: completed.
02
Drugs
silodosin
03
Conditions
ureteric stone
Beyond the preview
Go deeper on NCT05823662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05823662.